- LXRP
partners with Cultivating Wellness Inc. (“CW”) to formulate the ChrgD+
premium brand and will now focus on selling it to CW’s national
distribution network of retailers
- The
two-gram powder packets are water soluble and can be added to any hot/cold
beverage; they are a ready-mix hemp oil supplement that can be added to
drinks, such as coffee
- DehydraTECH
has already received multiple patents, and LXRP is a drug delivery
platform innovator; the introduction is seen as a first step in the
relationship between the companies
Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP)
introduction of ChrgD+ powder packets, which can add multi-spectrum hemp oil to
any hot or cold drink, leverages the trademarked ability of the company’s
DehydraTECH to deliver cannabinoids. LXRP’s partnership with Cultivating
Wellness Inc. (“CW”), which formulated the product, is seen as an important
combined effort (http://ibn.fm/HALyy).
LXRP has not only partnered with CW as the manufacturer of
ChrgD+; it also serves as the distributor of the product to its national
network of customers, such as convenience stores, specialty retailers, national
accounts and grocery chains. It is seen as the beginning of an important
partnership between the two companies.
In a news release, Chris Bunka, CEO of LXRP, said, “It’s a
simple way to add a multi spectrum powdered hemp supplement to your favorite
beverage at any time and enjoy its fast-acting, non-altered taste with no oily
residue. Lexaria’s ChrgD+ product format is being evaluated by others for use
in their psychoactive cannabinoids products sector as per our proven track
record as a technology provider to the industry.”
Based in British Columbia, Canada, LXRP is a biotechnology
company and drug delivery platform innovator that has developed DehydraTECH
technology, which has shown faster and more effective delivery of cannabinoids
and nicotine. LXRP’s IP portfolio already includes a patent for oral delivery
of all cannabinoids. The newest patents are to protect LXRP’s
cannabinoid-infused beverage compositions. The compositions use both non-psychoactive
cannabinoids, such as CBD, and also psychoactive cannabinoids, such as THC.
LXRP has a growing IP portfolio and will license in any of
the countries worldwide where its technology already has a patent or is
patent-pending. DehydraTECH is its proprietary absorption technology platform.
It hopes to be granted two new Australian patents by year’s end. If patents
applied for are issued, LXRP will then hold 12 issued patents within its first
patent family, “Food and Beverage Compositions Infused With Lipophilic Active
Agents and Methods of Use Thereof.” It recently received two new U.S. patents
related to cannabinoid-infused beverage compositions using DehydraTECH.
For more information, visit the company’s website at www.LexariaBioscience.com
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment